Endocrine and Metabolic Determinants of Cancer Risk Preface

被引：2

|

作者：

Holly, Jeff M. P. ^{[1
]}

机构：

[1] Univ Bristol, Southmead Hosp, Paul OGorman Lifeline Ctr, Dept Clin Sci N Bristol, Bristol BS10 5NB, Avon, England

来源：

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | 2008年 / 22卷 / 04期

关键词：

D O I：

10.1016/j.beem.2008.08.010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：VII / VIII

页数：2

相关论文

共 50 条

[1] ENDOCRINE DETERMINANTS OF RISK OF BREAST-CANCER
BULBROOK, RD
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1979, 11 (5-6): : R8 - R8
[2] Endocrine and metabolic agents - Preface
Roth, BD
Sliskovic, DR
CURRENT PHARMACEUTICAL DESIGN, 1999, 5 (09) : U2 - U2
[3] Endocrine and metabolic agents - Preface
Sliskovic, DR
CURRENT PHARMACEUTICAL DESIGN, 1999, 5 (01) : U2 - U2
[4] Endocrine and metabolic agents - Preface
Roth, BD
Sliskovic, DR
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (04) : U2 - U2
[5] Endocrine and metabolic agents - Preface
Sliskovic, DR
Roth, BD
CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (01) : U2 - U3
[6] Endocrine and metabolic emergencies - Preface
Wagner, MJ
Cowling, K
EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2005, 23 (03) : XV - XVI
[7] Endocrine and Metabolic Emergencies Preface
Willis, George C.
Pillow, M. Tyson
EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2014, 32 (02) : XVII - XVIII
[8] Endocrine and metabolic agents - Preface
Roth, BD
Sliskovic, DR
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (06) : U2 - U2
[9] Endocrine and metabolic agents - Preface
Sliskovic, DR
CURRENT PHARMACEUTICAL DESIGN, 1998, 4 (01) : U2 - U2
[10] Endocrine and metabolic agents - Preface
Wagman, AS
Cody, WL
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (28)

← 1 2 3 4 5 →